Inolex, a leading innovator in safe and sustainable preservation technology, has been granted a European patent for its groundbreaking preservation platform. The patent, EP3075401B1, focuses on paraben-free multifunctional compositions for topical cosmetic, toiletry, and pharmaceutical formulations that utilize Caprylhydroxamic Acid and a vicinal diol to protect against microbiological growth.
Inolex is also introducing Spectrastat™ CHA, a 100% natural Caprylhydroxamic Acid in powder form, to its line of preservation products. This new addition offers formulators a sustainable and effective option for broad spectrum microbial growth protection in cosmetic formulations.
Dr. Michael J. Fevola, VP of R&D at Inolex, explains that the company’s preservation technology utilizes a hurdle approach, combining different techniques to create an environment that is inhospitable to microbial growth. The combination of Caprylhydroxamic Acid with a vicinal diol, such as Caprylyl Glycol or Glyceryl Caprylate, forms the basis of Inolex’s broad spectrum preservation systems under the Spectrastat™ tradename.
Spectrastat™ CHA, derived from coconut, offers formulators maximum flexibility in designing their preservation systems. Whether choosing pre-optimized combinations from the Spectrastat™ line or creating custom formulations with individual ingredients like those from the Lexgard® range, Inolex provides a comprehensive platform for safe and sustainable preservation solutions.
For more information on Inolex’s proprietary preservation platform and the newly patented technology, visit www.inolex.com. With a focus on safety, sustainability, and innovation, Inolex continues to lead the way in the cosmetics industry.